Gestational diabetes mellitus in Greenland: a national study of prevalence and testing efficacy
Background: Within the last 20 years, the prevalence of gestational diabetes mellitus (GDM) has been reported to be increasing worldwide in correlation with ethnic and geographic variations. The actual prevalence of GDM throughout all of Greenland remains unknown. Objective: The aim of this study wa...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2016-08-01
|
Series: | International Journal of Circumpolar Health |
Subjects: | |
Online Access: | http://www.circumpolarhealthjournal.net/index.php/ijch/article/view/32167/pdf_91 |
_version_ | 1818038533886050304 |
---|---|
author | Michael Lynge Pedersen Jesper Olesen Marit Eika Jørgensen Peter Damm |
author_facet | Michael Lynge Pedersen Jesper Olesen Marit Eika Jørgensen Peter Damm |
author_sort | Michael Lynge Pedersen |
collection | DOAJ |
description | Background: Within the last 20 years, the prevalence of gestational diabetes mellitus (GDM) has been reported to be increasing worldwide in correlation with ethnic and geographic variations. The actual prevalence of GDM throughout all of Greenland remains unknown. Objective: The aim of this study was to estimate the prevalence of GDM among Greenlanders and non-Greenlanders living in Greenland and to estimate the efficacy of testing for GDM. Design: This study was performed as an observational, cross-sectional study including all women with permanent address in Greenland who had given birth to a singleton during 2014. The prevalence of GDM was calculated as the proportion of all pregnant women tested with a 75-g 2-h glucose tolerance test who had a 2-h capillary whole-blood glucose value of 8.5 mmol/l or above. Testing efficacy was calculated as the proportion of women who fulfilled the testing criteria who were actually tested in Greenland in 2014. Results: A total of 794 women (727 Greenlanders and 67 non-Greenlanders) were included in the study. The prevalence of GDM among tested women was 3.3% (confidence interval, CI: 0.9–5.6) among Greenlanders and 12.5% (CI: 0–25.7) among non-Greenlanders, corresponding, respectively, to 1.0% (CI: 0.3–1.3) and 4.5% (CI: 0–9.4) of all singleton pregnancies in Greenland in 2014. The overall testing efficacy was 69.0% among all eligible residents of Greenland and 85.1% among eligible residents in the capital city, Nuuk. Conclusion: In conclusion, the prevalence of GDM seems quite low in Greenland. Although diagnostic testing activity has improved within the last 6 years, still around one-third of all pregnant women in all Greenland fulfilling the testing criteria were not tested. Universal testing for GDM may be needed to improve testing of GDM in Greenland. |
first_indexed | 2024-12-10T07:44:15Z |
format | Article |
id | doaj.art-0f46f3bb08e34c74835725d732308754 |
institution | Directory Open Access Journal |
issn | 2242-3982 |
language | English |
last_indexed | 2024-12-10T07:44:15Z |
publishDate | 2016-08-01 |
publisher | Taylor & Francis Group |
record_format | Article |
series | International Journal of Circumpolar Health |
spelling | doaj.art-0f46f3bb08e34c74835725d7323087542022-12-22T01:57:14ZengTaylor & Francis GroupInternational Journal of Circumpolar Health2242-39822016-08-017501610.3402/ijch.v75.3216732167Gestational diabetes mellitus in Greenland: a national study of prevalence and testing efficacyMichael Lynge Pedersen0Jesper Olesen1Marit Eika Jørgensen2Peter Damm3 Greenland Center of Health Research, Institute of Nursing and Health Science, University of Greenland, Nuuk, Greenland Queen Ingrid Primary Health Care Center, Nuuk, Greenland Steno Diabetes Center, Gentofte, Denmark Center for Pregnant Women with Diabetes, Department of Obstetrics, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, DenmarkBackground: Within the last 20 years, the prevalence of gestational diabetes mellitus (GDM) has been reported to be increasing worldwide in correlation with ethnic and geographic variations. The actual prevalence of GDM throughout all of Greenland remains unknown. Objective: The aim of this study was to estimate the prevalence of GDM among Greenlanders and non-Greenlanders living in Greenland and to estimate the efficacy of testing for GDM. Design: This study was performed as an observational, cross-sectional study including all women with permanent address in Greenland who had given birth to a singleton during 2014. The prevalence of GDM was calculated as the proportion of all pregnant women tested with a 75-g 2-h glucose tolerance test who had a 2-h capillary whole-blood glucose value of 8.5 mmol/l or above. Testing efficacy was calculated as the proportion of women who fulfilled the testing criteria who were actually tested in Greenland in 2014. Results: A total of 794 women (727 Greenlanders and 67 non-Greenlanders) were included in the study. The prevalence of GDM among tested women was 3.3% (confidence interval, CI: 0.9–5.6) among Greenlanders and 12.5% (CI: 0–25.7) among non-Greenlanders, corresponding, respectively, to 1.0% (CI: 0.3–1.3) and 4.5% (CI: 0–9.4) of all singleton pregnancies in Greenland in 2014. The overall testing efficacy was 69.0% among all eligible residents of Greenland and 85.1% among eligible residents in the capital city, Nuuk. Conclusion: In conclusion, the prevalence of GDM seems quite low in Greenland. Although diagnostic testing activity has improved within the last 6 years, still around one-third of all pregnant women in all Greenland fulfilling the testing criteria were not tested. Universal testing for GDM may be needed to improve testing of GDM in Greenland.http://www.circumpolarhealthjournal.net/index.php/ijch/article/view/32167/pdf_91gestational diabetes mellitusprevalencescreeningInuitIndigenousGreenland |
spellingShingle | Michael Lynge Pedersen Jesper Olesen Marit Eika Jørgensen Peter Damm Gestational diabetes mellitus in Greenland: a national study of prevalence and testing efficacy International Journal of Circumpolar Health gestational diabetes mellitus prevalence screening Inuit Indigenous Greenland |
title | Gestational diabetes mellitus in Greenland: a national study of prevalence and testing efficacy |
title_full | Gestational diabetes mellitus in Greenland: a national study of prevalence and testing efficacy |
title_fullStr | Gestational diabetes mellitus in Greenland: a national study of prevalence and testing efficacy |
title_full_unstemmed | Gestational diabetes mellitus in Greenland: a national study of prevalence and testing efficacy |
title_short | Gestational diabetes mellitus in Greenland: a national study of prevalence and testing efficacy |
title_sort | gestational diabetes mellitus in greenland a national study of prevalence and testing efficacy |
topic | gestational diabetes mellitus prevalence screening Inuit Indigenous Greenland |
url | http://www.circumpolarhealthjournal.net/index.php/ijch/article/view/32167/pdf_91 |
work_keys_str_mv | AT michaellyngepedersen gestationaldiabetesmellitusingreenlandanationalstudyofprevalenceandtestingefficacy AT jesperolesen gestationaldiabetesmellitusingreenlandanationalstudyofprevalenceandtestingefficacy AT mariteikajørgensen gestationaldiabetesmellitusingreenlandanationalstudyofprevalenceandtestingefficacy AT peterdamm gestationaldiabetesmellitusingreenlandanationalstudyofprevalenceandtestingefficacy |